Morettini M, Burattini L, Gobl C, Pacini G, Ahren B, Tura A
Front Endocrinol (Lausanne). 2021; 12:611147.
PMID: 33828527
PMC: 8020816.
DOI: 10.3389/fendo.2021.611147.
Chadt A, Al-Hasani H
Pflugers Arch. 2020; 472(9):1273-1298.
PMID: 32591906
PMC: 7462924.
DOI: 10.1007/s00424-020-02417-x.
Liu Q, Zhang F, Zhang W, Pan A, Yang Y, Liu J
Theranostics. 2017; 7(16):4001-4012.
PMID: 29109794
PMC: 5667421.
DOI: 10.7150/thno.18788.
Edgerton D, Kraft G, Smith M, Farmer B, Williams P, Coate K
JCI Insight. 2017; 2(6):e91863.
PMID: 28352665
PMC: 5358484.
DOI: 10.1172/jci.insight.91863.
Xiao N, Lou M, Lu Y, Yang L, Liu Q, Liu B
Diabetologia. 2017; 60(6):1084-1093.
PMID: 28280902
DOI: 10.1007/s00125-017-4238-y.
Glucagon sensitivity and clearance in type 1 diabetes: insights from in vivo and in silico experiments.
Hinshaw L, Mallad A, Dalla Man C, Basu R, Cobelli C, Carter R
Am J Physiol Endocrinol Metab. 2015; 309(5):E474-86.
PMID: 26152766
PMC: 4556882.
DOI: 10.1152/ajpendo.00236.2015.
Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.
Meek T, Dorfman M, Matsen M, Fischer J, Cubelo A, Kumar M
Diabetes. 2015; 64(7):2376-87.
PMID: 25633417
PMC: 4477352.
DOI: 10.2337/db14-1562.
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.
Unger R, Cherrington A
J Clin Invest. 2012; 122(1):4-12.
PMID: 22214853
PMC: 3248306.
DOI: 10.1172/JCI60016.
Physiologic action of glucagon on liver glucose metabolism.
Ramnanan C, Edgerton D, Kraft G, Cherrington A
Diabetes Obes Metab. 2011; 13 Suppl 1:118-25.
PMID: 21824265
PMC: 5371022.
DOI: 10.1111/j.1463-1326.2011.01454.x.
The physiology of glucagon.
Taborsky Jr G
J Diabetes Sci Technol. 2010; 4(6):1338-44.
PMID: 21129328
PMC: 3005043.
DOI: 10.1177/193229681000400607.
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
Rebrin K, Steil G, Mittelman S, Bergman R
J Clin Invest. 1996; 98(3):741-9.
PMID: 8698866
PMC: 507484.
DOI: 10.1172/JCI118846.
Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/phosphorylation. Relation to the insulin-mediated inhibition of hepatic glucose production.
Rossetti L, Hu M
J Clin Invest. 1993; 92(6):2963-74.
PMID: 8254050
PMC: 288500.
DOI: 10.1172/JCI116919.
Degradation of intra- and extrahepatic protein by livers of normal and diabetic mice: differential responses to starvation.
Hutson N, Lloyd C, MORTIMORE G
Proc Natl Acad Sci U S A. 1982; 79(6):1737-41.
PMID: 6952225
PMC: 346055.
DOI: 10.1073/pnas.79.6.1737.
Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.
Wasserman D, Lickley H, Vranic M
J Clin Invest. 1984; 74(4):1404-13.
PMID: 6148356
PMC: 425308.
DOI: 10.1172/JCI111551.
Combined effects of cold and somatostatin on glucose kinetics in dogs.
MINAIRE Y, Forichon J, Dallevet G, Jomain M
Eur J Appl Physiol Occup Physiol. 1981; 46(3):249-59.
PMID: 6113959
DOI: 10.1007/BF00423401.
Effect of Escherichia coli lipopolysaccharide on the glucagon and insulin binding to isolated rat hepatocytes.
Pagani R, Portoles M, Municio A
Mol Cell Biochem. 1984; 65(1):37-44.
PMID: 6097807
DOI: 10.1007/BF00226017.
Effect of glucagon antibodies on plasma glucose, insulin and somatostatin in the fasting and fed rat.
Tan K, Tsiolakis D, Marks V
Diabetologia. 1985; 28(7):435-40.
PMID: 2864300
DOI: 10.1007/BF00280887.
Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Orskov L, Alberti K, Mengel A, Moller N, Pedersen O, Rasmussen O
Diabetologia. 1991; 34(7):521-6.
PMID: 1916058
DOI: 10.1007/BF00403290.
Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs.
Giacca A, Fisher S, Shi Z, Gupta R, Lickley H, Vranic M
J Clin Invest. 1992; 90(5):1769-77.
PMID: 1430203
PMC: 443235.
DOI: 10.1172/JCI116051.
